Louvina van der Laan

15PUBLICATIONS
43CO-AUTHORS
Infant and child healthPharmacogenomicsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 30, 2026
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35).

|Sep 09, 2026
Pharmacokinetics of Clofazimine Tablet Formulation in Children with Rifampicin-Resistant Tuberculosis in CATALYST, a Multi-Site International Trial.

|Aug 13, 2026
Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.

|Jan 08, 2026
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Ruvarashe J Madzime, Louvina van der Laan, Samantha du Toit

|May 29, 2025
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Megan Palmer, Yuanxi Zou, Anneke C Hesseling

|Feb 17, 2025
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Megan Palmer, Yuanxi Zou, Anneke C Hesseling

Pageof 3

Frequent Collaborators

12 joint publications

Anthony J Garcia-Prats

8 joint publications

Lubbe Wiesner

8 joint publications

Paolo Denti

6 joint publications

Belen Solans